APA (7th ed.) Citation

Elkoshi, Z., Behr, D., Mirimsky, A., Tsvetkov, I., & Danon, A. (2002). Multiple-Dose Studies can be a More Sensitive Assessment for Bioequivalence than Single-Dose Studies: The Case with Omeprazole. Clinical drug investigation, 22(9), 585-592. https://doi.org/10.2165/00044011-200222090-00003

Chicago Style (17th ed.) Citation

Elkoshi, Zeev, Dan Behr, Alex Mirimsky, Igor Tsvetkov, and Abraham Danon. "Multiple-Dose Studies Can Be a More Sensitive Assessment for Bioequivalence than Single-Dose Studies: The Case with Omeprazole." Clinical Drug Investigation 22, no. 9 (2002): 585-592. https://doi.org/10.2165/00044011-200222090-00003.

MLA (9th ed.) Citation

Elkoshi, Zeev, et al. "Multiple-Dose Studies Can Be a More Sensitive Assessment for Bioequivalence than Single-Dose Studies: The Case with Omeprazole." Clinical Drug Investigation, vol. 22, no. 9, 2002, pp. 585-592, https://doi.org/10.2165/00044011-200222090-00003.